Insights

Product Expansion Leverage Adamis’ FDA approved epinephrine and naloxone injection products to cross-sell allergy and overdose treatment solutions to healthcare providers and emergency departments already prescribing SYMJEPI and ZIMHI, while positioning for expanded access in episodic care settings.

Strategic Merger Opportunity The recent merger and DMK leadership integration present a window to collaborate on joint go-to-market strategies, co-marketing existing products, and accelerated capitalization for pipeline products in respiratory and inflammatory diseases.

Public Offering Momentum Capital raises and financing activity signal liquidity runway; target physicians and clinics with bundled product demonstrations and supplier partnerships to drive rapid adoption and inventory stocking for high-demand injectable therapies.

Clinical Pipeline Temporally align outreach around Tempeol, a COVID-19 related asset in Phase 2/3, to discuss compassionate use programs, clinical trial enrollments, and potential collaboration on companion diagnostics and patient access solutions.

Operational Scale With a lean team and mid-sized revenue, pursue partnerships with contract sales organizations, hospital distribution networks, and specialty pharmacies to scale commercialization of syringe-based injectables and expand payer coverage.

Similar companies to Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation Tech Stack

Adamis Pharmaceuticals Corporation uses 8 technology products and services including Amazon Web Services, Akamai, Drupal, and more. Explore Adamis Pharmaceuticals Corporation's tech stack below.

  • Cloud Hosting
  • Akamai
    Content Delivery Network
  • Content Management System
  • Webpack
    Development
  • Font Awesome
    Font Scripts
  • Modernizr
    Javascript Libraries
  • Acquia Cloud Platform
    Platform As A Service
  • Real User Monitoring

Media & News

Adamis Pharmaceuticals Corporation's Email Address Formats

Adamis Pharmaceuticals Corporation uses at least 3 email formats:
Adamis Pharmaceuticals Corporation Email FormatsExamplePercentage
FLast@adamispharmaceuticals.comJDoe@adamispharmaceuticals.com
100%
FLast@adamispharma.comJDoe@adamispharma.com
70%
Last@adamispharma.comDoe@adamispharma.com
30%

Frequently Asked Questions

What is Adamis Pharmaceuticals Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Adamis Pharmaceuticals Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adamis Pharmaceuticals Corporation's official website and social media links?

Minus sign iconPlus sign icon
Adamis Pharmaceuticals Corporation's official website is adamispharmaceuticals.com and has social profiles on LinkedIn.

How much revenue does Adamis Pharmaceuticals Corporation generate?

Minus sign iconPlus sign icon
As of October 2026, Adamis Pharmaceuticals Corporation's annual revenue is estimated to be $1M - $10M.

What is Adamis Pharmaceuticals Corporation's SIC code and NAICS code?

Minus sign iconPlus sign icon
Adamis Pharmaceuticals Corporation's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Adamis Pharmaceuticals Corporation have currently?

Minus sign iconPlus sign icon
As of October 2026, Adamis Pharmaceuticals Corporation has approximately 18 employees across 1 continents, including North America. Key team members include Vice President Of Operations: K. K. and Office Manager: T. F. Explore Adamis Pharmaceuticals Corporation's employee directory with LeadIQ.

What industry does Adamis Pharmaceuticals Corporation belong to?

Minus sign iconPlus sign icon
Adamis Pharmaceuticals Corporation operates in the Pharmaceuticals industry.

What technology does Adamis Pharmaceuticals Corporation use?

Minus sign iconPlus sign icon
Adamis Pharmaceuticals Corporation's tech stack includes Amazon Web Services, Akamai, Drupal, Webpack, Font Awesome, Modernizr, Acquia Cloud Platform and New Relic.

What is Adamis Pharmaceuticals Corporation's email format?

Minus sign iconPlus sign icon
Adamis Pharmaceuticals Corporation's email format typically follows the pattern of FLast@adamispharmaceuticals.com. Find more Adamis Pharmaceuticals Corporation email formats with LeadIQ.

How much funding has Adamis Pharmaceuticals Corporation raised to date?

Minus sign iconPlus sign icon
As of October 2026, Adamis Pharmaceuticals Corporation has raised $76M in funding. The last funding round occurred on Aug 04, 2023 for $52M.

When was Adamis Pharmaceuticals Corporation founded?

Minus sign iconPlus sign icon
Adamis Pharmaceuticals Corporation was founded in 2006.
Adamis Pharmaceuticals Corporation logo

Adamis Pharmaceuticals Corporation

PharmaceuticalsCalifornia, United States11-50 Employees

Adamis Pharmaceuticals is a small to mid-sized biopharmaceutical company based in the San Diego region, focused on developing and commercializing specialty medicines for allergy, opioid overdose, respiratory and inflammatory diseases. Its approved products include SYMJEPI epinephrine injections for emergency treatment of acute allergic reactions, including anaphylaxis, and ZIMHI naloxone injections for opioid overdose. Its development program includes Tempol, which is being studied for COVID-19 in a Phase 2/3 trial. In 2023, Adamis completed a merger with DMK Pharmaceuticals, signaling a notable corporate development. The company serves healthcare providers and patients requiring emergency and overdose therapies, positioning itself within the specialty pharmaceutical sector with established injectables and an ongoing development pipeline.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $76M

    Adamis Pharmaceuticals Corporation has raised a total of $76M of funding over 6 rounds. Their latest funding round was raised on Aug 04, 2023 in the amount of $52M as a Post IPO Equity.

  • $1M - $10M

    Adamis Pharmaceuticals Corporation's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.